Circulating levels of total angiopoietin-2 and the soluble Tie-2 receptor in women during ovarian stimulation and early gestation

Fertility and Sterility

Volumn 86, Issue 5, 2006, Pages 1531-1533

  Molskness, Theodore A ^a   Stouffer, Richard L ^a,b   Burry, Kenneth A ^b   Gorrill, Marsha J ^b   Lee, David M ^b   Patton, Phillip E ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR;

ADULT; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS LUTEUM; EMBRYO DEVELOPMENT; FEMALE; FEMALE INFERTILITY; HUMAN; OVARY; PLACENTA; PREGNANCY; PRIORITY JOURNAL; REPRODUCTION;

ADULT; ANGIOPOIETIN-2; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMANS; MENSTRUAL CYCLE; OVULATION INDUCTION; PREGNANCY; PREGNANCY TRIMESTER, FIRST; RECEPTOR, TIE-2; SOLUBILITY;

EID: 33750148108     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.03.045     Document Type: Article

References (10)

1. Geva E., and Jaffe R.B. Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertil Steril 74 (2000) 429-438
2. Hazzard T.M., and Stouffer R.L. Angiogenesis in ovarian follicular and luteal development. In: Arulkumaran S. (Ed). Clinical Obstetrics & Gynaecology. Angiogenesis in the female reproductive tract (2000), Bailliere Tindall, London (UK) 883-900
3. Suri C., Jones P., Patan S., Bartunkova S., Maisonpierre P., Davis S., et al. Requisite role of angiopoietin-1, a ligand for the Tie-2 receptor during embryonic angiogenesis. Cell 87 (1996) 1171-1180
4. Maisonpierre P.C., Suri C., Jones P.F., Bartunkova S., Wiegand S.J., Radziejewski C., et al. Angiopoietin-2, a natural antagonist for tie-2 that disrupts in vivo angiogenesis. Science 277 (1997) 55-60
5. Wulff C., Wilson H., Largue P., Duncan W.C., Armstrong D.G., and Fraser H.M. Angiogenesis in the human corpus luteum: localization and changes in angiopoietins, Tie-2, and vascular endothelial growth factor messenger ribonucleic acid. J Clin Endocrinol Metab 85 (2000) 4302-4309
6. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., and Holash J. Vascular-specific growth factors and blood vessel formation. Nature 407 (2000) 242-248
7. Xu F., Hazzard T.M., Evans A., Charnock-Jones S., Smith S., and Stouffer R.L. Intraovarian actions of antiangiogenic agents disrupt periovulatory events during the menstrual cycle in monkeys. Contraception 71 (2005) 239-248
8. Artini P.G., Fasciani A., Monti M., Luisi S., D'Ambrogio G., and Genazzani A.R. Changes in vascular endothelial growth factor levels and the risk of ovarian hyperstimulation syndrome in women enrolled in an in vitro fertilization program. Fertil Steril 70 (1998) 560-564
9. Lee A., Christenson L.K., Stouffer R.L., Burry K.A., and Patton P.E. Vascular endothelial growth factor levels in serum and follicular fluid of patients undergoing in vitro fertilization. Fertil Steril 68 (1997) 305-311
10. Geva E., Ginzinger D.G., Zaloudek C.J., Moore D.H., Byrne A., and Jaffe R.B. Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2. J Clin Endocrinol Metab 87 (2002) 4213-4224